Via National Keratoconus Foundation Corneal collagen cross-linking (CXL) has been shown to be an efficient treatment option to slow or halt the progression of keratoconus. As the US keratoconus community waits patiently (?) for FDA approval of basic corneal crosslinking, researchers in other countries are exploring advanced variations to improve this procedure. In biological and … Continue reading Three Different Protocols for CXL
fda
Bowman’s layer transplantation shows promise for keratoconus
Bowman’s layer transplantation reduced or stabilized corneal ectasia in eyes with keratoconus that were not eligible for corneal collagen cross-linking or intracorneal ring segments, according to a study presented here. “Historically, the treatment of keratoconus was limited to fitting contact lenses for as long as possible . . . and the patient was normally referred … Continue reading Bowman’s layer transplantation shows promise for keratoconus
Cornea specialist outlines ideal candidate for cross-linking for keratoconus
As corneal collagen cross-linking (CXL) makes its slow way through the USA FDA approval process, a presenter at SECO shared pearls of wisdom for patient selection and explained the procedure’s mechanism of action. Terry Kim, MD, chairman of the cornea department at Duke University School of Medicine, shared guidelines that he said are based on more … Continue reading Cornea specialist outlines ideal candidate for cross-linking for keratoconus
Keratoconus GB Living with Keratoconus 